Annual EBIT
-$129.84 M
-$3.88 M-3.08%
December 31, 2023
Summary
- As of February 6, 2025, CCCC annual earnings before interest & taxes is -$129.84 million, with the most recent change of -$3.88 million (-3.08%) on December 31, 2023.
- During the last 3 years, CCCC annual EBIT has fallen by -$64.11 million (-97.53%).
- CCCC annual EBIT is now -692.24% below its all-time high of -$16.39 million, reached on December 31, 2018.
Performance
CCCC EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$24.67 M
-$6.95 M-39.23%
September 30, 2024
Summary
- As of February 6, 2025, CCCC quarterly earnings before interest & taxes is -$24.67 million, with the most recent change of -$6.95 million (-39.23%) on September 30, 2024.
- Over the past year, CCCC quarterly EBIT has increased by +$1.20 million (+4.64%).
- CCCC quarterly EBIT is now -195.68% below its all-time high of -$8.34 million, reached on December 31, 2019.
Performance
CCCC Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$105.22 M
+$1.20 M+1.13%
September 30, 2024
Summary
- As of February 6, 2025, CCCC TTM earnings before interest & taxes is -$105.22 million, with the most recent change of +$1.20 million (+1.13%) on September 30, 2024.
- Over the past year, CCCC TTM EBIT has increased by +$26.73 million (+20.26%).
- CCCC TTM EBIT is now -952.09% below its all-time high of -$10.00 million, reached on September 30, 2019.
Performance
CCCC TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CCCC EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.1% | +4.6% | +20.3% |
| 3 y3 years | -97.5% | +4.6% | +20.3% |
| 5 y5 years | -692.2% | +4.6% | +20.3% |
CCCC EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -58.8% | at low | -63.1% | +32.6% | -28.7% | +23.5% |
| 5 y | 5-year | -290.0% | at low | -195.7% | +32.6% | -473.6% | +23.5% |
| alltime | all time | -692.2% | at low | -195.7% | +32.6% | -952.1% | +23.5% |
C4 Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$24.67 M(+39.2%) | -$105.22 M(-1.1%) |
| Jun 2024 | - | -$17.72 M(-37.5%) | -$106.42 M(-14.2%) |
| Mar 2024 | - | -$28.36 M(-17.7%) | -$124.03 M(-4.5%) |
| Dec 2023 | -$129.84 M(+3.1%) | -$34.48 M(+33.3%) | -$129.84 M(-1.6%) |
| Sep 2023 | - | -$25.87 M(-26.8%) | -$131.95 M(-4.0%) |
| Jun 2023 | - | -$35.32 M(+3.4%) | -$137.48 M(+6.5%) |
| Mar 2023 | - | -$34.17 M(-6.6%) | -$129.04 M(+2.4%) |
| Dec 2022 | -$125.96 M(+54.1%) | -$36.58 M(+16.5%) | -$125.96 M(+20.5%) |
| Sep 2022 | - | -$31.40 M(+16.8%) | -$104.49 M(+7.5%) |
| Jun 2022 | - | -$26.88 M(-13.6%) | -$97.23 M(+5.2%) |
| Mar 2022 | - | -$31.09 M(+105.7%) | -$92.40 M(+13.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$81.75 M(+24.4%) | -$15.12 M(-37.4%) | -$81.75 M(-7.1%) |
| Sep 2021 | - | -$24.14 M(+9.5%) | -$88.01 M(+3.2%) |
| Jun 2021 | - | -$22.05 M(+7.9%) | -$85.30 M(+15.1%) |
| Mar 2021 | - | -$20.44 M(-4.4%) | -$74.09 M(+12.7%) |
| Dec 2020 | -$65.73 M(+97.4%) | -$21.38 M(-0.3%) | -$65.73 M(+24.7%) |
| Sep 2020 | - | -$21.44 M(+97.9%) | -$52.70 M(+27.7%) |
| Jun 2020 | - | -$10.83 M(-10.3%) | -$41.26 M(+35.6%) |
| Mar 2020 | - | -$12.08 M(+44.8%) | -$30.42 M(+65.9%) |
| Dec 2019 | -$33.30 M(+103.2%) | -$8.34 M(-16.6%) | -$18.34 M(+83.4%) |
| Sep 2019 | - | -$10.00 M | -$10.00 M |
| Dec 2018 | -$16.39 M | - | - |
FAQ
- What is C4 Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for C4 Therapeutics?
- What is C4 Therapeutics annual EBIT year-on-year change?
- What is C4 Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for C4 Therapeutics?
- What is C4 Therapeutics quarterly EBIT year-on-year change?
- What is C4 Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for C4 Therapeutics?
- What is C4 Therapeutics TTM EBIT year-on-year change?
What is C4 Therapeutics annual earnings before interest & taxes?
The current annual EBIT of CCCC is -$129.84 M
What is the all time high annual EBIT for C4 Therapeutics?
C4 Therapeutics all-time high annual earnings before interest & taxes is -$16.39 M
What is C4 Therapeutics annual EBIT year-on-year change?
Over the past year, CCCC annual earnings before interest & taxes has changed by -$3.88 M (-3.08%)
What is C4 Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of CCCC is -$24.67 M
What is the all time high quarterly EBIT for C4 Therapeutics?
C4 Therapeutics all-time high quarterly earnings before interest & taxes is -$8.34 M
What is C4 Therapeutics quarterly EBIT year-on-year change?
Over the past year, CCCC quarterly earnings before interest & taxes has changed by +$1.20 M (+4.64%)
What is C4 Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of CCCC is -$105.22 M
What is the all time high TTM EBIT for C4 Therapeutics?
C4 Therapeutics all-time high TTM earnings before interest & taxes is -$10.00 M
What is C4 Therapeutics TTM EBIT year-on-year change?
Over the past year, CCCC TTM earnings before interest & taxes has changed by +$26.73 M (+20.26%)